Company: INTS
Filing Date: 2025-09-09
Form Type: DEF 14A
Source: 0001567264-25-000090
Chunk: 25

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-09-09
Form: DEF 14A
Chunk 25
---
                    |     |           |     |                      |     |   |
| Leonard Batterson(9)                                       |     |                    |     | 2,476,213 |     |                      | 5.0 | % |
| * Less than 1%                                             |     |                    |     |           |     |                      |     |   |

(1) Includes 722,227 shares of common stock issuable upon the exercise of options that are exercisable within sixty days of August 31, 2025. Does not include 776,153 shares of common stock underlying options that are not exercisable within sixty days of August 31, 2025. The principal business address of Mr. Bender is c/o Intensity Therapeutics, Inc., 1 Enterprise Drive, Suite 430, Shelton, CT 06484.

(2) Includes 250,952 shares of common stock issuable upon the exercise of options that are exercisable within sixty days of August 31, 2025. Does not include 556,427 shares of common stock underlying options that are not exercisable within sixty days of August 31, 2025.

(3) Includes 140,762 shares of common stock issuable upon the exercise of options that are exercisable within sixty days of August 31, 2025. Does not include 159,516 shares of common stock underlying options that are not exercisable within sixty days of August 31, 2025.

(4) Includes 129,000 shares of common stock issuable upon the exercise of options that are exercisable within sixty days of August 31, 2025. Does not include 68,750 shares of common stock underlying options that are not exercisable within sixty days of August 31, 2025.

(5) Includes 119,000 shares of common stock issuable upon the exercise of options that are exercisable within sixty days of August 31, 2025. Does not include 68,750 shares of common stock underlying options that are not exercisable within sixty days of August 31, 2025.

<div align='center'>14</div>

(6) Includes 56,250 shares of common stock issuable upon the exercise of options that are exercisable within sixty days of August 31, 2025. Does not include 68,750 shares of common stock underlying options that are not exercisable within sixty days of August 31, 2025.

(7) Includes 37